Clinical Case Studies Week 2 (Dyslipidaemia, Acute and Chronic Pain, Thyroid disorders) Flashcards

1
Q

Nonpharmacological modification of lipids?

A
  • reducing intake of saturated and trans fats
  • replacing saturated fats with monounsaturated and polyunsaturated fats
  • increasing intake of soluble fibre
  • Limiting alcohol intake, losing weight (if overweight or obese) and increasing physical activity also improve lipid levels.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When should pharmacological treatment be started in addition to diet and lifestyle modifications for dyslipidemia? Provide TWO different scenarios.

A

Adults over the age of 60 with diabetes = equivalent to high risk >15%

In those with established cardiovascular, cerebrovascular or peripheral vascular disease or in those without established disease but at high CVD risk (>15%)

If inadequate response to 3-6 months of lifestyle modification in those at moderate risk (10-15%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the first-line drug choice of lipid-lowering drugs (for hypercholesterolaemia)? What does lead to reduce risk of?

A

Statins

1st line for hypercholesterolaemia

Most effective oral LDL lowering agent

Reduce risk of MI, stroke, revascularisation procedures and mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dose of high intensity statins? When to use high intensity statins?

A

Start a high dose of a high-potency statin in all patients who have had a cardiovascular event.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If high-intensity statin therapy is not required, appropriate dose ranges of statins are?

A

Simvastain 80mg associated with greater risk of myopathy than other statin therapies with similar LDL-C-lowering efficacy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the factors that increase the risk of statin-related adverse effects?

A

pre-existing muscle, liver or kidney disease, high-dose or high-potency therapy, concurrent drugs, concurrent illness, frailty and advanced age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the typical adverse effects of statins?

A

Muscle symptoms

  • Muscle symptoms (eg muscle pain, tenderness or weakness) are commonly reported by patients taking statin

Features of stain related muscle symptoms:

  • aching or stiffness (rather than shooting pain or cramping)
  • pain located in the large muscle groups (eg thighs, buttocks)
  • onset 4 to 6 weeks after starting or increasing the dose of a statin
  • Elevated serum ck concentration that decreases with statin withdrawal

> Statin therapy may continue in a patient without symptoms, provided serum CK concentration does not exceed 5 times the upper limit of normal (ULN)

Rhabdomyolysis

  • Damaged muscle fibers enter the bloodstream
  • The serum CK concentration is typically elevated by at least 10 times the ULN
  • Do not restart statin therapy in patients who had confirmed rhabdomyolysis.

Glucose metabolism

  • Statin therapy may slightly impair glucose metabolism, and has been associated with a small increase in new-onset diabetes, primarily in patients with pre-existing risk factors for diabetes
  • doesn’t affect the decision to start statin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

If statin is causing muscle symptoms, what to do?

A

Avoid complete discontinuation of statins; consider trialling an alternative statin, low-dose therapy, or intermittent dosing (eg alternate-daily dosing). Continuing statin therapy is important to reduce cardiovascular risk.

  • Statin therapy may continue in a patient without symptoms, provided serum CK concentration does not exceed 5 times the upper limit of normal (ULN)
  • If more than this –> cease statin for at least 6 to 8 weeks until CK is in normal range
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When is ezetimibe used? What is the dose?

A

Option when statins are contraindicated or not tolerated, may be added to statin when statin alone is insufficient.

  • Decreases LDL-C by 15 to 20%
  • Ezetimibe 10 mg orally, daily.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What can ezetimibe cause when added to a statin?

A

Ezetimibe can cause muscle pain and mild elevation of alanine aminotransferase (ALT), but when added to a statin it does not appear to increase the incidence of these adverse effects beyond the level seen with statin monotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When are fibrates used? What is it the first choice for? What is the dose?

A

Option when statins are contraindicated or not tolerated

> can be added to statin therapy if triglycerides remain elevated despite the maximum tolerate dose of a statin –> also reduce LDL

> do not add gemfibrozil to statin therapy –> increases risk of myositis

First choice for hypertriglyceridaemia

  • fenofibrate 145mg orally if eGFR more than 60mL/min
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What to advise patient about fibrates?

A
  • Seek medical advice promptly if urine is dark (brown) or if there is any muscle pain, tenderness or weakness
  • avoid exposure of skin to sun, wear protective clothing and use sunscreen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When to use proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors?

A

Consider using a PCSK9 inhibitor if the LDL-C target is not achieved with the maximum tolerated dose of a statin

> add to a statin

> evolocumab and alirocumab

> subcut injection fortnightly or monthly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How to treat severely elevated triglycerides above 10mmol/L?

A

fenofibrate plus fish oil

  • fish oil (equivalent to 2 to 4 g of omega-3 fatty acids) orally, daily

> statin therapy reduces CVD risk in these patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Bile acid binding resins, what are they used with? Dose?

A

Bile acid binding resins are mainly used in combination with statins, but they can be used alone or in combination with other drugs, including ezetimibe

  • colestyramine 4 to 8 g orally, daily, increasing if required up to 24 g daily in divided doses
  • colestipol 5 to 10 g orally, daily, increasing if required up to 30 g daily in divided doses

> Gastrointestinal adverse effects limit the maximum dose for many patients and are a common reason for nonadherence to therapy

> drug must be thoroughly mixed with an adequate volume of fluid (eg fruit juice) to minimise upper gastrointestinal tract disturbance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What happens when statin conbined with warfarin? Which statins do this?

A

Fluvastatin, rosuvastatin and simvastatin may increase warfarin’s anticoagulant effect, increasing the risk of bleeding

< use atorvastatin or pravastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Acute and chronic pain from this card onwards..

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Nonpharmacological management of acute pain

A

presence of familiar support person

application of heat or cold or vibration device

menthol or heat cream rubs

warm soak

humour

counting

stress balls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

pharmacological management of acute pain?

A

Mild pain: paracetamol + NSAID

Moderate pain: add low dose opioid

Severe pain: add higher dose opioid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is multimodal analgesia?

A

Multimodal analgesia aims to improve pain relief due to additive or synergistic effects of different drugs

  • pain relief is improved if paracetamol, a nonsteroidal anti-inflammatory drug (NSAID) or a gabapentinoid is added to an opioid regimen
  • Most commonly, multimodal analgesia is used to decrease the opioid dosage required (‘opioid-sparing’) and the likelihood of opioid-related adverse effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Tapering and stopping analgesics for acute pain?

A

In general, taper and stop fentanyl, morphine and oxycodone before tramadol and tapentadol; paracetamol and NSAIDs should be the last drugs discontinued.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Oral drugs for mild, acute nociceptive pain in adults?

A
  • Paracetamol immediate-release 1 g orally, 4-to 6-hourly. Maximum 4 g in 24 hours

+ NSAID = improved pain relief is achieved compared wwith either drug alone = synergistic

  • celecoxib 100 to 200 mg orally, twice daily –> safest in renal impairment, less likely to cause GI toxicity, lesslikely to cause CVD side effects.
  • ibuprofen 200 to 400 mg orally, 3 times daily
  • naproxen 250 to 500 mg orally, twice daily

diclofenac associated with higest risk of cardiovascular toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Why dont use modified release opioids for acute pain?

> includes transdermal patches

A

Cant be safely or rapidly titrated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Oral drugs for moderate, acute nociceptive pain in adults? What opioids are used at what dose?

A

Paracetamol + NSAID + PLUS (if pain is not expected to be relieved with paracetamol plus an NSAID) ONE OF THE FOLLOWING OPIOIDS

  • Tapentadol 50mg orally 4-6 hourly if required –> increase dose to 100mg orally 4-6 hourly if required
  • Tramadol 50mg orally 4-6 hourly if required, increase dose 100mg orally 4-6 hourly if required
  • Morphine 7.5 mg every 4 hours
  • Oxycodone 5 to 15mg orally
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What type of opioids can/cant be used in severe acute nociceptive pain?

A

Opioids that are full mu-receptor agonists (eg morphine) are preferred for severe, acute nociceptive pain;

tramadol or tapentadol are unlikely to provide adequate relief of severe pain because their dosing is limited by effects at other receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the doses of opioids used along with paracetamol and NSAIDs for acute pain?

A

Morphine 20mg orally every 2 hours if required

  • Patients above 65 years old, 10mg orally every 2 hours if required

Oxycodone 10mg orally every 2 hours if required

  • Patients above 65 years old, use 5mg orally every 2 hours if required
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

When can chronic pain develop following acute pain?

A

Chronic pain (pain that persists or recurs longer than 3 months) can develop following acute pain due to an acute illness, injury or trauma (eg shingles infection, surgery, whiplash).

28
Q

What prevents transition from acute to chronic pain?

A

Adequate acute pain management may prevent the transition from acute to chronic pain.

  • early diagnosis of neuropathic pain, which is a key component of many chronic pain conditions that occur after an acute event
  • Psychological support and patient education regarding analgesia and pain expectations may also reduce the transition from acute to chronic pain
29
Q

What does chronic pain management help patients and carers accomplish?

A

Understand chronic pain, reduce central sensitisation and pain intensity, and improve social, emotional and physical functioning.

30
Q

What is first line treatment in chronic non-cancer pain?

A

Multidimensional approach

  • increasing social connections
  • addressing thoughts and emotions
  • increasing physical activity
  • improving nutrition
  • improving sleep.
31
Q

What is used for chronic nocieptive pain?

A

Limited evidence of paracetamol + NSAIDs

32
Q

What to use for chronic neuropathic pain?

A

Adjuvants

  • TCA (amitryptilline and nortripytilline) –> 1st line
  • SNRI (duloxetine and venlafaxine) –> 1st line
  • Pregabalin and gabapentin –> 2nd line
33
Q

What are the doses of adjuvants used in chronic neuropathic pain?

A
34
Q

How to start an opioid in chronic non-cancer pain? Tips and advice.

A

Opioids have a time-limited benefit, generally no longer than 3 months

Consider use of paracetamol for opioid sparing benefits

  • Duration: acceptable trial period is up to 8 weeks, syccess or failure should be determined within 2-4 weeks
  • Formulation and dose: start at a low dose, any response should be evident at oral morphine equivalent dose at less than 60mg
35
Q

What opiods to use in chronic pain (cancer pain)

A

Use a SR opioid regularly and calculate a prn IR dose for breakthrough or incident pain

  • Always use opioids in combination with other analgesics
  • The size of the breakthrough dose should be 1/6th – 1/12th (5%-15%) of the patient’s 24-hour baseline opioid dose
36
Q

Summary of non-pharmacological techniques in acute and chronic pain

A

Non-pharmacological techniques

Physical, social and psychological –> imp in both acute and chronic pain

acute pain

RICE = Relative rest, ice, compression, elevation AND Early mobilisation is important in most cases AND Discourage reliance on passive modalities

chronic pain

Physical therapies

> Encourage body to make it’s own endogenous opioids, reduce falls risk, reduces muscle atrophy and improves gait

> Meditative movement tx can help sleep, depression, fatigue and QOL

> Pacing vs boom and bust

> Discourage reliance on passive modalities

CBT

37
Q

Thryoid disorders from this card onwards…

A
38
Q

primary hypothyroidism?

A

elevated serum TSH concentration

39
Q

primary thyrotoxicosis?

A

suppressed serum TSH concentration

40
Q

What drugs can cause hypothyroidism?

A

iodine excess, lithium, amiodarone, interferon alfa, interleukin-2, tyrosine kinase inhibitors (eg sunitinib, sorafenib), immune checkpoint inhibitors (eg ipilimumab, nivolumab, pembrolizumab, atezolizumab)

41
Q

Typical symptoms of hypothyroidism

A

fatigue, weight gain, cold intolerance, constipation and dry skin

42
Q

Hypothyroidism is associated with an increased incidence of cardiovascular risk factors, such as?

A

hypercholesterolaemia, high blood pressure, and left ventricular systolic dysfunction

43
Q

Primary hypothyroidism refers to a disorder within the thyroid gland that reduces the production or secretion of?

A

thyroid hormones (thyroxine [T4] and triiodothyronine [T3])

  • results in an elevated serum TSH concentration.
  • (Hashimoto thyroiditis)
44
Q

Primary hypothyroidism is treated with?

A

thyroxine replacement therapy (levothyroxine),

45
Q

Decision to treat hypothyroidism?

A

whether the patient has overt or subclinical disease

> overt = high TSH and low T4 conc

> subclinical: high TSH and normal T4 conc, often asymptomatic

whether the patient is symptomatic

the degree of thyroid stimulating hormone (TSH) elevation.

46
Q

Overt symptomatic primary hypothyroidism is a clear indication to start treatment with levothyroxine. True or false

A

True

47
Q

Subclinical asymptomatic primary hypothyroidism with a serum TSH concentration above 10 milliunits/L indicates a high risk of progression to overt disease. true or false

A

true

48
Q

Dose for initial full treatment of levothyroxine?

A

levothyroxine 1.6 micrograms/kg (to the nearest 25 micrograms) orally, daily. Adjust the dose every 4 to 8 weeks as required

49
Q

Initial partial replacement is recommended for patients with only mildly elevated serum thyroid stimulating hormone (TSH) concentration or subclinical disease. It is also recommended for patients with cardiovascular disease because a high starting dose can precipitate or exacerbate cardiac ischaemia. What is the initial partial replacement dose for levothyroxine?

A

levothyroxine 25 to 50 micrograms orally, daily. Adjust the dose every 4 to 8 weeks as required

50
Q

What TSH conc to aim for?

A

For patients younger than 60 years, aim for a serum TSH concentration between 0.5 and 2.5 milliunits/L

> For patients 60 years and older, a reasonable serum TSH target range is 1 to 5 milliunits/L.

51
Q

Once levothyroxine therapy is stabilised, measure serum TSH concentration

A

at about 3 and 6 months and anually thereafter

52
Q

Patitent counselling for levothyroxine (tmt for hypothyroidism)? What are the interactions?

A

Cholestyramine, iron and calcium supplements, raloxifene, fibre supplement - affects absorption

Amiodarone, iodine containing contrast media, kelp supplements - contain large doses of iodine

COC, rifampicin – decrease concentration of thyroxine

Best taken on empty stomach

53
Q

The principles of thyroxine replacement therapy for pregnant women are the same as for nonpregnant adults, although more frequent testing and dose adjustment may be required to maintain euthyroidism. True or False

A

True

54
Q

During a healthy pregnancy, thyroid hormone production increases by up to 50%. To avoid undertreatment, particularly in the first trimester, women already taking levothyroxine before pregnancy usually require a 25 to 30%. True or false.

A

True

55
Q

How does a myxoedema coma occur? What are the symptoms? How to treat?

A

Severe hypothyroidism with physiological decompensation

Sx: Bradycardia, hypotension, hypothermia, delayed deep tendon reflex and coma

Treament (must be treated aggressively): Liothyronine (T3) + hydrocortisone

Seek source of infection and treat aggressively

Treat heart failure and arrhythmias should they arise

Monitor body temperature and treat hypothermia

Monitor urea, electrolytes and haematological indices

56
Q

Thyrotoxicosis refers to the clinical condition that results from excess

A

excess thyroid hormones (thyroxine [T4] and triiodothyronine [T3]) in body tissue, regardless of the cause

  • Most common causes of hyperthyroidism are Graves disease
57
Q

Common symptoms of thyrotoxicosis include?

A

weight loss, heat intolerance, tremor, muscle weakness and palpitations.

58
Q

Thyrotoxicosis is usually indicated by a low or suppressed serum thyroid stimulating hormone (TSH) concentration. T or F

A

True

59
Q

first-line drug for initial treatment of hyperthyroidism? Dose?

A

Carbimazole

  • carbimazole 30 to 45 mg orally, daily in 2 or 3 divided doses. Adjust the dose at 4- to 6-weekly intervals as require –> significant symptoms
  • carbimazole 10 to 20 mg orally, daily in 2 or 3 divided doses. Adjust the dose at 4- to 6-weekly intervals as required –> mild symptoms
60
Q

What to assess every 4 to 6 weeks for thyrotoxicosis?

A

Continue to assess clinical and biochemical response every 4 to 6 weeks, adjusting the dose of the antithyroid drug to achieve thyroid hormone concentrations in the normal range

61
Q

Adverse effects of antithyroid drugs (carbimazole and propylthiouracil)

A

rarely cause agranulocytosis; it is most likely to occur in the first months of therapy.

Advise patients to immediately stop the drug and to seek medical assessment if they experience acute malaise, fever or infection (typically severe pharyngitis).

Propylthiouracil has been associated with rare cases of severe liver injury causing death or requiring liver transplantation

62
Q

Whats CI and precautions for antithyroid drug therapy?

A

previous severe adverse reaction to antithyroid drug therapy

liver disease

63
Q

a beta blocker can be used to rapidly improve some symptoms of thyrotoxicosis (eg palpitations, tremor, sweating). Which beta blockers are sued?

A

atenolol 25 mg orally, once daily, increasing as required according to heart rate up to 50 mg daily

propranolol 10 mg orally, twice daily, increasing as required according to heart rate up to 40 mg twice daily.

or if CI

> diltiazem 60 mg orally, 4 times daily.

64
Q

Thyrotoxicosis can increase drug clearance, leading to increased dose requirements of many drugs. If a patient is taking other drugs, review the doses after starting treatment to control thyrotoxicosis

A

True

65
Q

Thyrotoxicosis can cause atrial fibrillation. Do not use amiodarone to manage atrial fibrillation caused by thyrotoxicosis because it contains iodine, which impairs the response to antithyroid drugs

A

True

66
Q

a lower than normal dose of warfarin may be required in thyrotoxicosis

A

true

67
Q

Carbimazole therapy should have been switched to propylthiouracil before conception, as it is associated with less severe congenital abnormalities. T or F? What to measure

A

true

Measure maternal serum TSH and T4 concentrations every 4 to 6 weeks in a patient who is stable and euthyroid on treatment